|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 20 F Sreet NW |
Address2 | Suite 310 C |
| City | Washington |
State | DC |
Zip Code | 20001-6704 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 288373-12
|
||||||||
|
6. House ID# 370930000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Iain Mackay Adams |
Date | 1/20/2026 10:25:55 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Physician Payments:
H.R. 879- Medicare Patient Access and Practice Stabilization Act of 2025 ; Would stop the 2.8% payment cut from January 1 - December 31, 2025, and provides a partial inflation update of 2%.
Medicaid Cuts:
Urging Congress to preserve Medicaids vital role in the healthcare system and explore solutions that maintain access to high-quality care, particularly for underserved communities.
Access to Care:
H.R. 1509/ S.752- The Accelerating Kids Access to Care Act; Would require state Medicaid programs to establish a process through which qualifying out-of-state providers may temporarily treat children without undergoing additional screening requirements. It also requires pass-through pricing models for covered drugs under Medicaid.
H.R. 2433- Reducing Medically Unnecessary Delays in Care Act; Requires Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria that is developed in consultation with physicians.
H.R. 4331- The Access to Claims Data Act; Would require the Centers for Medicare & Medicaid Services (CMS) to establish a program that allows clinician-led clinical data registries access to Medicare claims data for research, quality of care measurement, and reporting.
Educating members on the need for updates to the physician fee schedule with an annual update based on a portion of the growth in the Medicare Economic Index (MEI).
Educating members about the damage caused by the CY 2026 MPFS which introduced a 2.5% reduction in work Relative Value Units (RVUs) for non-time-based procedures with additional reductions scheduled every three years.
Educating members about the harm caused by CMS reducing the indirect practice expense (PE) allocated per work RVU allocated to facility services to 50% of the amount allocated for non-facility (office-based) services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Haley |
Brown |
|
|
|
Molly |
Peltzman |
|
|
|
Iain |
Adams |
|
|
|
Rachel |
Pollock |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Expanding GME opportunities:
H.R. 3890- Resident Physician Shortage Reduction Act; Adds 14,000 new residency slots over seven years, starting in 2026.
Loan Repayment:
H.R.2028/ S.942- Resident Education Deferred Interest (REDI) Act; Would permit a pause on student loan interest accrual and principal loan repayment for the duration of medical residencies and fellowships.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Haley |
Brown |
|
|
|
Molly |
Peltzman |
|
|
|
Iain |
Adams |
|
|
|
Rachel |
Pollock |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Lung Cancer:
H.R.4417/ S. 2927- Mobile Cancer Screening Act; Would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer screening units, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live.
S.1157/H.R. 2319- Women in Lung Cancer Research; Would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers.
NIH Funding:
Calling for the protection of NIH indirect funding.
CDC Funding:
Urging the continuation of CDC funding for Firearms Violence Research and the Office of Smoking Health.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Haley |
Brown |
|
|
|
Molly |
Peltzman |
|
|
|
Iain |
Adams |
|
|
|
Rachel |
Pollock |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Workforce:
S. 266/ H.R. 929- The Dr. Lorna Breen Healthcare Provider Protection Act; Would reauthorize a grant program for healthcare organizations and professional associations for employee education on strategies to reduce burnout, peer-support programming, and mental and behavioral health treatment for five years. Communities with a shortage of health care workers, rural communities, and those experiencing burnout due to administrative burdens, such as lengthy paperwork, will be prioritized.
H.R.3178 - The Save Health Care Workers Act; Would make it a federal crime to assault or intimidate hospital workers.
S. 2031 - Workforce Mobility Act; Aims to prohibit certain noncompete agreements.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Haley |
Brown |
|
|
|
Molly |
Peltzman |
|
|
|
Iain |
Adams |
|
|
|
Rachel |
Pollock |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Telehealth:
S. 1261- CONNECT for Health Act; Would permanently remove all geographic restrictions on telehealth services and expand originating sites to the location of the patient, including homes, among other provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Iain |
Adams |
|
|
|
Molly |
Peltzman |
|
|
|
Haley |
Brown |
|
|
|
Rachel |
Pollock |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R.2414-Reauthorize a military and civilian partnership for trauma readiness grant program aka "Mission Zero"
Securing Defense funding for Lung Cancer Research.
Ensuring Military Readiness of Surgeons.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Iain |
Adams |
|
|
|
Haley |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |